8 Ken Fisher Celldex Therapeutics Trades
Ken Fisher acquired 452 Thousand Celldex Therapeutics shares worth $8.83 Million. That's 0.00% of their equity portfolio (427th largest holding). The first Celldex Therapeutics trade was made in Q3 2022. Since then Ken Fisher bought shares four more times and sold shares on three occasions. The investor's estimated purchase price is $16.5 Million, resulting in a loss of 46%.
Avg closing price
Price range
Increased shares by 20.9% (+78.1 Thousand shares)
Q4 2024
Avg closing price
$27.13
Price range
$23.31
-
$32.40
Increased shares by 210.6% (+254 Thousand shares)
Q3 2024
Avg closing price
$38.12
Price range
$32.06
-
$44.56
Sold 2.7% shares (-3.29 Thousand shares)
Q2 2024
Avg closing price
$37.73
Price range
$32.76
-
$42.56
Increased shares by 467.7% (+102 Thousand shares)
Q1 2024
Avg closing price
$41.06
Price range
$35.22
-
$51.88
Increased shares by 6.2% (+1.27 Thousand shares)
Q4 2023
Avg closing price
$29.41
Price range
$22.61
-
$40.65
Sold 29.2% shares (-8.48 Thousand shares)
Q1 2023
Avg closing price
$43.15
Price range
$34.78
-
$47.43
Sold 14.4% shares (-4.88 Thousand shares)
Q4 2022
Avg closing price
$35.70
Price range
$27.78
-
$45.38
New holding (+33.9 Thousand shares)
Q3 2022
Avg closing price
$30.66
Price range
$22.70
-
$37.57
